Nicotinic Acid – Pharmacokinetics, Pharmacodynamics, Receptor Expression
Condition(s):HealthyLast Updated:March 15, 2006Unknown status
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:March 15, 2006Unknown status
Condition(s):Type 2 DiabetesLast Updated:November 28, 2023Recruiting
Condition(s):Cardiovascular Diseases; Heart Diseases; Coronary Disease; Atherosclerosis; Myocardial InfarctionLast Updated:May 14, 2018Completed
Condition(s):Obsessive-Compulsive DisorderLast Updated:July 14, 2023Recruiting
Condition(s):Glaucoma, Open-AngleLast Updated:November 13, 2023Not yet recruiting
Condition(s):COVID-19 InfectionLast Updated:February 18, 2022Unknown status
Condition(s):Sarcopenia; Nicotinamide Adenine Dinucleotide Concentration; Muscle Quality and NAD+ ContentLast Updated:October 26, 2023Recruiting
Condition(s):Elevated Lipoprotein(a) LevelsLast Updated:August 4, 2009Unknown status
Condition(s):HyperphosphatemiaLast Updated:May 23, 2017Unknown status
Condition(s):Ischemia Reperfusion Injury; Myocardial Injury; Acute Kidney InjuryLast Updated:July 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.